Cianergoline
A detailed overview of the pharmacological compound Cianergoline
Drug Information | |||
---|---|---|---|
Image | 250 | ||
Identifiers
ATC Code DrugBank UNII KEGG ChEBI IUPAC Name |
Chemical Data
C H N O Molecular Weight |
Cianergoline is a pharmacological compound that acts as a dopamine receptor agonist. It is primarily used in research settings to study its effects on the central nervous system and its potential therapeutic applications.
Pharmacology[edit | edit source]
Cianergoline is known to interact with dopamine receptors, particularly the D2 subtype. This interaction is believed to modulate neurotransmitter release and influence various physiological processes, including mood regulation, motor control, and endocrine function.
Mechanism of Action[edit | edit source]
Cianergoline exerts its effects by binding to dopamine receptors in the brain, mimicking the action of endogenous dopamine. This binding leads to the activation of intracellular signaling pathways that result in altered neuronal activity and neurotransmitter release.
Pharmacokinetics[edit | edit source]
The pharmacokinetic profile of Cianergoline includes hepatic metabolism and renal excretion. The exact bioavailability and half-life of the drug are not well-documented, but it is known to be administered orally.
Clinical Applications[edit | edit source]
While Cianergoline is not widely used in clinical practice, its role as a dopamine agonist makes it a candidate for research into conditions such as Parkinson's disease, prolactinoma, and other disorders associated with dopaminergic dysfunction.
Research and Development[edit | edit source]
Research on Cianergoline has focused on its potential to modulate dopaminergic pathways and its effects on prolactin secretion. Studies have explored its use in animal models to better understand its pharmacodynamics and potential therapeutic benefits.
Safety and Side Effects[edit | edit source]
As with other dopamine agonists, Cianergoline may cause side effects such as nausea, dizziness, and hypotension. Long-term use and high doses may lead to more serious effects, including impulse control disorders and cardiac valvulopathy.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD